Aldeyra Therapeutics, Inc. (ALDX)

4.24 +0.10 (+2.42%) USD  |  NASDAQ  |  Jan 14, 16:00
4.25 +0.01 (+0.24%) Pre-Market: 20:00
More

Aldeyra Therapeutics Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for ALDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Exelixis, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Anavex Life Sciences Corp. --